Biomerica Inc. Common Stock (BMRA)

About BMRA

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complicati…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

53

Website

biomerica.com/

Fundamentals

1-day range

$2.01$2.15

Market cap

$4.73M

P/E (trailing)

—

P/E (forward)

5.49

EPS (trailing)

$-1.59

Dividend yield

—

Beta

0.44

Avg. volume

63.7K

Biomerica Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BMRA

  Biomerica Inc. Common Stock

  $2.14

  ▲ 1.67%
  Market cap $4.73MP/E —
  $1.45$3.31
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.84

  ▼ 1.60%
  Market cap $4.85MP/E —
  $0.97$7.91
• VRAX

  Virax Biolabs Group Limited Ordinary Shares

  $2.82

  ▼ 4.08%
  Market cap $2.34MP/E —
  $2.5$21.75
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $162.42MP/E —
  $2.33$8.51
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $284.15MP/E —
  $1.91$7.84
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $648.81MP/E —
  $2.62$8.61
• NTLA

  Intellia Therapeutics Inc. Common Stock

  $12.87

  ▼ 1.83%
  Market cap $1.50BP/E —
  $7.95$28.25

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
  Benzinga · 8/28/2026
• Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share
  benzinga · 8/27/2026
• Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share
  Benzinga · 8/27/2026

• Chin Eric · August 26, 2026 · Buy

  6.3K @ $1.6
• MOATAZEDI DAVID · August 26, 2026 · Buy

  10.0K @ $1.6
• Irani Zackary S. · August 26, 2026 · Buy

  31.3K @ $1.6
• BARBIERI ALLEN · August 26, 2026 · Buy

  20.0K @ $1.6
• Gary M. Huff · August 20, 2026 · Buy

  31.3K @ $1.6

Institutional Ownership

March 31, 2026

Total shares held

101.5K

Total value held

$214.5K

Institutional holders

9